tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Facial Nerve Injuries D020220 1 associated lipids
Intertrigo D007402 1 associated lipids
Miller Fisher Syndrome D019846 1 associated lipids
Cholangitis, Sclerosing D015209 1 associated lipids
Hepatic Insufficiency D048550 1 associated lipids
Lung Abscess D008169 1 associated lipids
Central Nervous System Viral Diseases D020805 1 associated lipids
Hypoplastic Left Heart Syndrome D018636 1 associated lipids
Mite Infestations D008924 1 associated lipids
Polyendocrinopathies, Autoimmune D016884 1 associated lipids
Leukoplakia D007971 1 associated lipids
Fasciitis, Necrotizing D019115 1 associated lipids
Mediastinal Emphysema D008478 1 associated lipids
Angiolymphoid Hyperplasia with Eosinophilia D000796 1 associated lipids
Eye Infections, Viral D015828 1 associated lipids
Dysplastic Nevus Syndrome D004416 1 associated lipids
Lichenoid Eruptions D017512 1 associated lipids
Lymphocele D008210 1 associated lipids
Colitis, Collagenous D046729 1 associated lipids
Malacoplakia D008287 1 associated lipids
Myoclonic Cerebellar Dyssynergia D002527 1 associated lipids
Lichen Nitidus D017513 1 associated lipids
Feline Infectious Peritonitis D016766 1 associated lipids
Meningitis, Cryptococcal D016919 1 associated lipids
Oculomotor Nerve Diseases D015840 1 associated lipids
Cutis Laxa D003483 1 associated lipids
Invasive Pulmonary Aspergillosis D055744 1 associated lipids
Intestinal Volvulus D045822 1 associated lipids
Hand Injuries D006230 1 associated lipids
Beckwith-Wiedemann Syndrome D001506 1 associated lipids
Eye Diseases, Hereditary D015785 1 associated lipids
Hepatopulmonary Syndrome D020065 1 associated lipids
Herpes Labialis D006560 1 associated lipids
End Stage Liver Disease D058625 1 associated lipids
Nocturnal Myoclonus Syndrome D020189 1 associated lipids
Uveomeningoencephalitic Syndrome D014607 1 associated lipids
Myelitis D009187 1 associated lipids
IgG Deficiency D017099 1 associated lipids
Deltaretrovirus Infections D006800 1 associated lipids
Dendritic Cell Sarcoma, Interdigitating D054739 1 associated lipids
Polymyositis D017285 1 associated lipids
Scorpion Stings D065008 1 associated lipids
Rotavirus Infections D012400 1 associated lipids
Netherton Syndrome D056770 1 associated lipids
Pseudohypoaldosteronism D011546 1 associated lipids
Arm Injuries D001134 1 associated lipids
Intussusception D007443 1 associated lipids
Thrombotic Microangiopathies D057049 1 associated lipids
Autoimmune Diseases of the Nervous System D020274 1 associated lipids
Lupus Erythematosus, Discoid D008179 1 associated lipids
Lymphocytic Choriomeningitis D008216 1 associated lipids
Erythroplasia D004919 1 associated lipids
Hepatic Veno-Occlusive Disease D006504 1 associated lipids
West Nile Fever D014901 1 associated lipids
Hypoalbuminemia D034141 1 associated lipids
AIDS-Associated Nephropathy D016263 1 associated lipids
Oral Ulcer D019226 1 associated lipids
Epidermolysis Bullosa Dystrophica D016108 1 associated lipids
Primary Graft Dysfunction D055031 1 associated lipids
Esophageal Perforation D004939 1 associated lipids
Epididymitis D004823 1 associated lipids
Pruritus Vulvae D011539 1 associated lipids
Central Serous Chorioretinopathy D056833 1 associated lipids
Feline Acquired Immunodeficiency Syndrome D016181 1 associated lipids
Budd-Chiari Syndrome D006502 1 associated lipids
Porokeratosis D017499 1 associated lipids
Lentigo D007911 1 associated lipids
Mutism D009155 1 associated lipids
Amyloid Neuropathies D017772 1 associated lipids
Cervical Intraepithelial Neoplasia D018290 1 associated lipids
Migraine with Aura D020325 1 associated lipids
Denys-Drash Syndrome D030321 1 associated lipids
Akinetic Mutism D000405 1 associated lipids
Sleep Apnea, Central D020182 1 associated lipids
Orchitis D009920 1 associated lipids
Phyllodes Tumor D003557 1 associated lipids
Meningitis, Fungal D016921 1 associated lipids
Malocclusion, Angle Class II D008312 1 associated lipids
Flaviviridae Infections D018178 1 associated lipids
Idiopathic Interstitial Pneumonias D054988 1 associated lipids
Dysuria D053159 1 associated lipids
Cardiomyopathy, Restrictive D002313 1 associated lipids
Paraparesis, Tropical Spastic D015493 1 associated lipids
Neurodermatitis D009450 1 associated lipids
Posterior Leukoencephalopathy Syndrome D054038 1 associated lipids
Ecthyma, Contagious D004474 1 associated lipids
Priapism D011317 1 associated lipids
Vulvar Lichen Sclerosus D007724 1 associated lipids
Hypophosphatemia D017674 1 associated lipids
Leukemia, Myeloid, Chronic-Phase D015466 1 associated lipids
Myelinolysis, Central Pontine D017590 1 associated lipids
Protoporphyria, Erythropoietic D046351 1 associated lipids
Smooth Muscle Tumor D018235 1 associated lipids
Coproporphyria, Hereditary D046349 1 associated lipids
Ichthyosiform Erythroderma, Congenital D016113 1 associated lipids
Panniculitis, Lupus Erythematosus D015435 1 associated lipids
Retrognathia D063173 1 associated lipids
Mediastinal Diseases D008477 1 associated lipids
Tinea Capitis D014006 1 associated lipids
Digestive System Fistula D016154 1 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Mor E et al. Comparison of short and long-term renal function in liver transplant patients receiving cyclosporin or FK 506. 1994 Transpl. Int. pmid:11271340
Uemoto S et al. Long-term use of FK 506 in living related liver transplantation. 1994 Transpl. Int. pmid:11271341
Dmitrewski J et al. Steroid withdrawal 3 months after liver transplantation--does FK 506 confer any advantage over cyclosporin? 1994 Transpl. Int. pmid:11271342
von Schnakenburg C et al. Post-transplant epididymitis and orchitis following Listeria monocytogenes septicaemia. 2000 Pediatr Transplant pmid:11272610
Martel J et al. [Subcutaneous mycosis due to Scopulariopsis brevicaulis in an immunocompromised patient]. 2001 Ann Dermatol Venereol pmid:11275588
Tahara K et al. Experimental small bowel transplantation using newborn intestine in rats: III. Long-term cryopreservation of rat newborn intestine. 2001 J. Pediatr. Surg. pmid:11283886
Krisp A and Hoffmann R [Letter concerning the article by E.C.Bornhövd, E.Schuller, T.Bieber, A.Wollenberg: "Immunosuppressive macrolides and their use in dermatology". Der Hautarzt (2000) 51:646-654]. 2001 Hautarzt pmid:11284076
Schwrer H et al. Pantoprazole and cyclosporine or tacrolimus. 2001 Aliment. Pharmacol. Ther. pmid:11284790
Kasper RC et al. Anetoderma arising in cutaneous B-cell lymphoproliferative disease. 2001 Am J Dermatopathol pmid:11285407
Trimarchi H et al. Cyclosporine-associated thrombotic microangiopathy during daclizumab induction: a suggested therapeutic approach. 2001 Nephron pmid:11287781
Fredduzzi S et al. Nitro-aspirin (NCX4016) reduces brain damage induced by focal cerebral ischemia in the rat. 2001 Neurosci. Lett. pmid:11290402
Lunz JG et al. Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs. 2001 Am. J. Pathol. pmid:11290556
Zoeteweij JP et al. Targeted inhibition of calcineurin signaling blocks calcium-dependent reactivation of Kaposi sarcoma-associated herpesvirus. 2001 Blood pmid:11290600
Fortin JF et al. Regulation of nuclear factor of activated T cells by phosphotyrosyl-specific phosphatase activity: a positive effect on HIV-1 long terminal repeat-driven transcription and a possible implication of SHP-1. 2001 Blood pmid:11290602
van Gelder T et al. Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid. 2001 Ther Drug Monit pmid:11294511
Macchi-Andanson M et al. Failure of traditional trough levels to predict tacrolimus concentrations. 2001 Ther Drug Monit pmid:11294512
Lener EV et al. Successful treatment of erosive lichen planus with topical tacrolimus. 2001 Arch Dermatol pmid:11295919
Ishikawa M et al. [Blood concentrations and side effects of tacrolimus in a living renal transplantation]. 2001 Masui pmid:11296433
Yada T et al. Its8, a fission yeast homolog of Mcd4 and Pig-n, is involved in GPI anchor synthesis and shares an essential function with calcineurin in cytokinesis. 2001 J. Biol. Chem. pmid:11297516
Griffiths CE Ascomycin: an advance in the management of atopic dermatitis. 2001 Br. J. Dermatol. pmid:11298524
Harper J et al. First experience of topical SDZ ASM 981 in children with atopic dermatitis. 2001 Br. J. Dermatol. pmid:11298537
Luger T et al. SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis. 2001 Br. J. Dermatol. pmid:11298538
Li S et al. Combined host-conditioning with CTLA4-Ig, tacrolimus, anti-lymphocyte serum, and low-dose radiation leads to stable mixed hematopoietic chimerism. 2001 Exp. Hematol. pmid:11301194
Arima H et al. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus. 2001 J. Pharmacol. Exp. Ther. pmid:11303042
Shiraishi S et al. Up-regulation of cell surface sodium channels by cyclosporin A, FK506, and rapamycin in adrenal chromaffin cells. 2001 J. Pharmacol. Exp. Ther. pmid:11303055
Mardini M et al. Cyclosporine and FK506 differentially regulate the sarcolemmal Na(+)-K(+) pump. 2001 J. Pharmacol. Exp. Ther. pmid:11303073
Trotter JF et al. Liver transplantation using sirolimus and minimal corticosteroids (3-day taper). 2001 Liver Transpl. pmid:11303295
Jones NF et al. Comparison of long-term immunosuppression for limb transplantation using cyclosporine, tacrolimus, and mycophenolate mofetil: implications for clinical composite tissue transplantation. 2001 Plast. Reconstr. Surg. pmid:11304605
Topical tacrolimus for treatment of atopic dermatitis. 2001 Med Lett Drugs Ther pmid:11309535
Sheehy EC et al. Oral health in children undergoing liver transplantation. 2000 Int J Paediatr Dent pmid:11310095
Monegal A et al. Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A. 2001 Calcif. Tissue Int. pmid:11310351
Freyschmidt-Paul P et al. Current and potential agents for the treatment of alopecia areata. 2001 Curr. Pharm. Des. pmid:11311114
Rumora L et al. MKP-1 as a target for pharmacological manipulations in PC12 cell survival. 2001 Neurochem. Int. pmid:11311446
Yoshimoto T et al. Cyclosporin A, but not FK506, prevents the downregulation of phosphorylated Akt after transient focal ischemia in the rat. 2001 Brain Res. pmid:11311876
Takatsuki M et al. Analysis of alloreactivity and intragraft cytokine profiles in living donor liver transplant recipients with graft acceptance. 2001 Transpl. Immunol. pmid:11316071
Smith KM and Van Etten RA Activation of c-Abl kinase activity and transformation by a chemical inducer of dimerization. 2001 J. Biol. Chem. pmid:11320088
Pohanka E et al. [Dosage and monitoring of tacrolimus after kidney transplantation]. 2000 Dtsch. Med. Wochenschr. pmid:11320722
Russell RK et al. Systemic absorption with complications during topical tacrolimus treatment for orofacial Crohn disease. 2001 J. Pediatr. Gastroenterol. Nutr. pmid:11321395
Strestíková P et al. Different mechanisms in inhibition of rat macrophage nitric oxide synthase expression by FK 506 and cyclosporin A. 2001 Immunopharmacol Immunotoxicol pmid:11322650
Gaziev D and Lucarelli G Novel approaches to the treatment of chronic graft-versus-host disease. 2001 Expert Opin Investig Drugs pmid:11322865
Lang-Lazdunski L et al. The effects of FK506 on neurologic and histopathologic outcome after transient spinal cord ischemia induced by aortic cross-clamping in rats. 2001 Anesth. Analg. pmid:11323353
Kennedy DS and Linden GJ Resolution of gingival overgrowth following change from cyclosporin to tacrolimus therapy in a renal transplant patient. 2000 J Ir Dent Assoc pmid:11323935
Weinberg JM and Silverberg NB A kinder, gentler therapy? 2001 Cutis pmid:11324387
Kulkarni P Review: uveitis and immunosuppressive drugs. 2001 J Ocul Pharmacol Ther pmid:11324985
Kawada N et al. Role of mast cells in antigen-induced airway inflammation and bronchial hyperresponsiveness in rats. 2001 Jpn. J. Pharmacol. pmid:11325017
Sche PP et al. Corrigendum to: "Display cloning: functional identification of natural product receptors using cDNA-phage display" [Chemistry & Biology 6 (1999) 707-716]. 2001 Chem. Biol. pmid:11325595
Mollee P et al. Combination therapy with tacrolimus and anti-thymocyte globulin for the treatment of steroid-resistant acute graft-versus-host disease developing during cyclosporine prophylaxis. 2001 Br. J. Haematol. pmid:11328304
Dicarlo JB and McCall CO Pharmacologic alternatives for severe atopic dermatitis. 2001 Int. J. Dermatol. pmid:11328387
Mittal N et al. Tacrolimus and diarrhea: pathogenesis of altered metabolism. 2001 Pediatr Transplant pmid:11328543
Frühwirth M et al. Rotavirus infection as cause of tacrolimus elevation in solid-organ-transplanted children. 2001 Pediatr Transplant pmid:11328545